Search results
Theralase(R) Technology Effective in Virus Inactivation
The Joplin Globe· 2 days agoTORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
Theralase(R) Technology Effective in Virus Inactivation
Morningstar· 2 days agoTORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type...
Morningstar· 7 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by three months the target action date of its priority review ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 4 days agoQIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAstat-Dx Gastrointestinal Panel 2 in the United States. The launch comes after the recent clearance of ...
Life as a teen without social media isn't easy. These families are navigating adolescence offline
McComb Enterprise-Journal· 1 day agoKate Bulkeley uses her phone to print textbook pages while Sutton packs art materials ahead of a ski vacation, Friday, Feb. 16, 2024, in Westport, Conn. It is hard to be a teenager today without ...
Lab-grown meat isn't on store shelves yet, but some states have already banned it
The Chippewa Herald· 5 days agoLab-grown meat is not available in any U.S. grocery stores or restaurants. Florida and Arizona...
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
Morningstar· 7 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by three months the target action date of its priority review ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoFor the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers ...
SARCOMA CLINICAL TRIAL FUNDED BY STAND UP TO CANCER REDUCES RISK OF RELAPSE BY 43%
Tehachapi News· 3 days agoFor the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers ...
